Regeneration method of cartilage.

A technology of cartilage and chondrocytes, applied in the field of regenerative medicine, can solve problems such as transient, tumorigenic, and short-term effects of growth factors, and achieve the effect of enhancing ability, reducing side effects, and lasting effects

Pending Publication Date: 2020-03-17
SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, the method of cartilage regeneration mainly achieves the purpose of regeneration by adding growth factors in vitro to promote its growth and expansion, but the growth factors are uncertain and have risks such as tumorigenesis; the added growth factors need to be varied and must reach a certain concentration to meet the needs of cell growth ; There are many uncertainties in exogenous growth factors, and there are risks of tumorigenesis; the effect of growth factors is short-lived and transient; growth factors may also act on other cells at the same time, resulting in uncontrollable results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Regeneration method of cartilage.
  • Regeneration method of cartilage.

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] This embodiment provides a cartilage regeneration method, which is a cartilage regeneration method based on gene transfection. The regeneration method includes the step of transfecting the target gene hsa-miR-193b-3p into chondrocytes.

[0030] In the step of transfecting the target gene hsa-miR-193b-3p into the chondrocytes, the target gene is transfected into the chondrocytes by the lentiviral vector, and at 35-39° C. and 4-6% CO 2 Incubate for 48-72 hours under the incubator conditions.

[0031] The regeneration method also includes: the step of culturing the transfected chondrocytes in vitro. In the step of culturing the transfected chondrocytes in vitro, the chondrocytes after successful transfection are routinely cultured in vitro to form a perichondrium sheet, that is, to obtain a cartilage regeneration material.

[0032] The acquisition of the chondrocytes comprises the following steps:

[0033] Take the residual ear cartilage discarded during the operation, c...

Embodiment 2

[0036] This embodiment provides a cartilage regeneration method, which includes the step of transfecting the target gene hsa-miR-193b-3p into chondrocytes.

[0037] In the step of transfecting the target gene hsa-miR-193b-3p into chondrocytes, the target gene is transfected into human chondrocytes by a lentiviral vector, and at 37° C. and 5% CO 2 Incubate for 60 hours in an incubator.

[0038] The regeneration method also includes: the step of culturing the transfected chondrocytes in vitro.

[0039] In the step of culturing the transfected chondrocytes in vitro, the chondrocytes after successful transfection are routinely cultured in vitro for 4 weeks to form a perichondrium sheet, that is, to obtain cartilage regeneration material.

[0040] The target gene contains GFP fluorescence, which is used to detect whether the target gene is successfully transfected into the chondrocytes.

[0041] The acquisition of the chondrocytes comprises the following steps:

[0042] Take the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a regeneration method of cartilage. The regeneration method comprises the step: transfecting a target gene hsa-miR-193b-3p into cartilage cells. According to the disclosed method, the target gene hsa-miR-193b-3p is successfully transfected into human cartilage cells and intervention is carried out from the cell source required by regeneration, so that cell amplification andextracellular matrix secretion capacity is enhanced and the side reactions are reduced as much as possible. Therefore, the cartilage cell characteristics are improved from the source and the purposeof efficiently promoting cartilage regeneration is achieved.

Description

technical field [0001] The invention relates to the technical field of regenerative medicine, in particular to a cartilage regeneration method based on gene transfection. Background technique [0002] At present, the method of cartilage regeneration mainly achieves the purpose of regeneration by adding growth factors in vitro to promote its growth and expansion, but the growth factors are uncertain and have risks such as tumorigenesis; the added growth factors need to be varied and must reach a certain concentration to meet the needs of cell growth ; There are many uncertainties in exogenous growth factors, and there are risks of tumorigenesis; the effect of growth factors is short-lived and transient; growth factors may also act on other cells at the same time, resulting in uncontrollable results. [0003] Therefore, there is an urgent need to provide a cartilage regeneration method based on gene transfection to solve the above problems and achieve the purpose of efficientl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/867
CPCC12N5/0654C12N15/86C12N2510/00C12N2740/15043C12N2500/84
Inventor 陈霞张如鸿
Owner SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap